| | |

Depression After Mesothelioma Diagnosis: Women Are at Highest Risk

depression after mesothelioma diagnosis

White women are more likely than other patients to experience depression after mesothelioma diagnosis. 

That word comes from researchers at the University of Florida. The team analyzed the cases of more than 120,000 patients with late-stage cancer. 

Although all patients face a risk of depression with an advanced cancer diagnosis, the problem appears to be worse among white women. 

The research team says understanding how cancer news affects patients can help doctors avoid diagnosis bias.  

Cancer Records from the SEER Database

The Florida study provides important insights into who is likely to get depression after mesothelioma diagnosis. 

The study included 123,066 advanced cancer cases from the Surveillance Epidemiology and End Results (SEER) database. All study subjects received their diagnosis between 2001 and 2013.

Although the study did not focus specifically on mesothelioma patients, it did include lung cancer patients. Pleural mesothelioma shares many common characteristics with lung cancer. It is almost always diagnosed at an advanced stage.

Is Depression After Mesothelioma Diagnosis Rising?

The study revealed that depression after mesothelioma diagnosis is likely to be higher today than it was even six years ago. From 2001 to 2013, the incidence of depression among advanced cancer patients rose nearly nine percent. 

Most cases of depression arose within the first three months after a stage IV cancer diagnosis. 

Among the more than 19,000 non-Hispanic white patients, one in five reported depression. In non-Hispanic black patients, the number dropped to 15.9 percent. Hispanic cancer patients had the lowest incidence of depression at 12.7 percent. 

Gender may also play a role in depression after mesothelioma diagnosis. Twenty-two percent of women in the study reported depression versus 16 percent of men. 

“Non-Hispanic whites and females were still independent predictors of higher risk of postdiagnosis depression,” conclude the researchers. 

Managing Post-Diagnosis Depression

For people at higher risk of depression after mesothelioma diagnosis, staying active may help.

  • A 2017 study found that mesothelioma patients who give up activities they used to love are more prone to depression.
  • Last year, Australia’s Clinical Oncology Society recommended exercise as “a safe and effective intervention” to counteract the psychological effects of cancer and treatment. 

Another study earlier this year finds mesothelioma surgery may also help. Although their depression spiked in the months immediately after surgery, peritoneal mesothelioma patients were happier two years after surgery than before it. 

Source: 

Huo, J, et al, “Patterns of Postdiagnosis Depression Among Late-Stage Cancer Patients: Do Racial/Ethnic and Sex Disparities Exist?”, July 11, 2019, American Journal of Clinical Oncology, Epub ahead of print, https://insights.ovid.com/crossref?an=00000421-900000000-98798

Cormie, P, et al, “Clinical Oncology Society of Australia position statement on exercise in cancer care”, May 7, 2018, The Medical Journal of Australia, Epub ahead of print

Ali, YM, et al, “Effect of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Quality of Life in Patients with Peritoneal Mesothelioma”, May 8, 2019, Annals of Surgical Oncology, Epub ahead of print, https://www.ncbi.nlm.nih.gov/pubmed/31069554

Similar Posts

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Treatment Uses Herpes Virus to Shrink Mesothelioma Tumors

    Researchers at a hospital in Sheffield, England are testing a potential new mesothelioma treatment based on the same virus that causes herpes. The small-scale trial is the first in the world to test the modified herpes simplex virus, HSV1716, in human mesothelioma patients. HSV1716 has been genetically engineered to infect and kill cancer cells without harming healthy cells. In laboratory studies on mesothelioma and some other cancers, it has been shown to be effective at shrinking tumors while causing limited toxicity. Just as significantly, HSV1716 increased survival rates among mice with various human cancers. The Phase I/II trial at Sheffield Experimental Cancer Medicine Centre is the next stage in development of HSV1716 as a viable mesothelioma treatment. The goal of…